Author Archives: Antigone Barton

Rajiv Shah moves on, leaving mixed legacy, lingering questions

By on .

In November 2009, with a Congress contemplating a foreign aid overhaul, the news that a physician had just been named to take the long-vacant helm at the United States Agency for International Development came as a heartening sign to global health advocates. It was a sign, advocates hoped, that aggressive action against diseases that prey […]

With $30 million worth of bedaquiline, drug maker donates 30,000 courses of TB treatment

By on .

Global TB response advocates express continued concern about drug’s price First, a word about the significance of bedaquiline. The first new antituberculosis drug to be developed in nearly half a century, it was given fast-tracked approval by the U.S. Food and Drug Administration at the end of 2012 to speed access to the drug for […]

Ebola survivors in Sierra Leone, peer support and science in Zambia, and a groundbreaking activist group reflects on a year of challenges . . . We’re reading why affected community inclusion changes everything

By on .

CDC reports on Ebola survivors – As living proof that Ebola is not inevitably fatal, survivors of the current outbreak in West Africa have valuable stories to tell. With the possibility of some acquired immunity to the virus, they also may be better able than others to fill needed roles of caregivers and burial team […]

Universal health coverage requires quality healthcare access for stigmatized populations

By on .

The following is a guest post by Ron MacInnis, Deputy Director for HIV, Health Policy Project, Futures Group, Arin Dutta, Senior Economist, Health Policy Project, Futures Group and Andrew Zapfel, Policy Analyst, Health Policy Project, Futures Group In order to celebrate progress and hold leaders accountable, the global community has recognized December 12th as Universal […]

Congressional emergency Ebola spending in bill follows, falls short of President’s request, while CDC delineates ongoing impacts of crisis

By on .

While the emergency Ebola money in the Congressional spending bill released Tuesday allots nearly a billion dollars less overall than the $6.18 billion President Obama requested in November for responses to the crisis in West Africa and its impacts at home, the $5.2 billion in the omnibus bill closely follows most aspects of the President’s […]

HIV dollars drop with waning philanthropic funds . . . and a goodbye to England’s Rose

By on .

Like a candle in the wind, support for HIV responses risks burning out long before the epidemic ever will . . . On one hand, the Elton John AIDS Foundation, one of the top 20 philanthropic funders of HIV responses is still going strong, with more than $17 million in disbursements last year and a […]

South Africa’s Treatment Action Campaign needs help: We’re reading about TAC’s contributions to global health and human rights, and how the world can give back

By on .

When some day AIDS ends as a global threat, the group that started in the country with the greatest burden of the disease in the world, and formed its life-saving mission to confront the toll of the disease around human rights, dignity and equality, will take its place, and its share of credit in history. […]

Beating TB requires more than medicine: The value of patient support

By on .

The following is a guest post by Emily Delmotte of Management Sciences for Health Eight years ago Busisiwe Beko was undergoing treatment for multidrug-resistant tuberculosis when, after months of waiting to see a pediatric specialist, her daughter was diagnosed with the same illness. The five-month-old baby was admitted to a TB hospital where she would […]

Rosemary Namubiru is free: A case of reckless, negligent reporting continues

By on .

“This was not, contrary to what sections of society wanted us to believe, a case against those living with HIV.” Ugandan Judge Rugadya Atwoki, on the case of Rosemary Namubiru The judge who weighed Rosemary Namubiru’s appeal on a conviction of “doing a negligent act likely to spread infection of disease” stemming from a workplace […]